184 related articles for article (PubMed ID: 35501515)
21. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
[TBL] [Abstract][Full Text] [Related]
22. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
[TBL] [Abstract][Full Text] [Related]
23. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
[TBL] [Abstract][Full Text] [Related]
24. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
Ridderheim M; Bjurberg M; Gustavsson A
Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
[TBL] [Abstract][Full Text] [Related]
25. Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
Coolbrandt A; T'Jonck A; Blauwens K; Dejaeger E; Neven P; Punie K; Vancoille K; Wildiers H
Breast Cancer Res Treat; 2021 Apr; 186(3):715-722. PubMed ID: 33452953
[TBL] [Abstract][Full Text] [Related]
26. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
[TBL] [Abstract][Full Text] [Related]
27. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N
Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015
[TBL] [Abstract][Full Text] [Related]
28. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
[TBL] [Abstract][Full Text] [Related]
29. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review.
Marks DH; Qureshi A; Friedman A
JAMA Dermatol; 2018 Dec; 154(12):1465-1472. PubMed ID: 30383138
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Acta Oncol; 2014 Jan; 53(1):80-7. PubMed ID: 24059270
[TBL] [Abstract][Full Text] [Related]
32. "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Bajpai J; Kagwade S; Chandrasekharan A; Dandekar S; Kanan S; Kembhavi Y; Ghosh J; Banavali SD; Gupta S
Breast; 2020 Feb; 49():187-193. PubMed ID: 31865282
[TBL] [Abstract][Full Text] [Related]
33. The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.
Mustoe MM; Lee CM; Melisko ME; Esserman LJ; Rugo HS
Future Oncol; 2018 Oct; 14(24):2461-2469. PubMed ID: 30001151
[TBL] [Abstract][Full Text] [Related]
34. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
Nomizu T; Ueo H; Kato M; Fukuma E
Gan To Kagaku Ryoho; 2023 Mar; 50(3):321-325. PubMed ID: 36927900
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
[TBL] [Abstract][Full Text] [Related]
37. The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia.
Schaffrin-Nabe D; Schmitz I; Josten-Nabe A; von Hehn U; Voigtmann R
Oncol Res Treat; 2015; 38(10):489-95. PubMed ID: 26451590
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
Pedersini R; Fornaro C; di Mauro P; Bianchi S; Vassalli L; Amoroso V; Gelmi M; Ardine M; Rodella F; Cosentini D; Dalla Volta A; Turla A; Pierini M; Motta P; Conti E; Simoncini EL; Berruti A
Int J Nurs Pract; 2021 Jun; 27(3):e12888. PubMed ID: 32959460
[TBL] [Abstract][Full Text] [Related]
39. Low temperature mitigating the paclitaxel-induced damages in mouse cell and hair follicle model.
Chen L; Xu Y; Ye X
Biochem Biophys Res Commun; 2022 May; 603():94-101. PubMed ID: 35279463
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting.
Saad M; Chong FLT; Bustam AZ; Ho GF; Malik RA; Ishak WZW; Ee Phua VC; Yusof MM; Yap NY; Alip A
Indian J Cancer; 2018; 55(2):157-161. PubMed ID: 30604728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
